Transgenic swine: Expression of human CD39 protects against myocardial injury
- 31 May 2012
- journal article
- research article
- Published by Elsevier BV in Journal of Molecular and Cellular Cardiology
- Vol. 52 (5), 958-961
- https://doi.org/10.1016/j.yjmcc.2012.01.002
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Transgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injuryJournal of Molecular and Cellular Cardiology, 2011
- The in-situ pig heart with regional ischemia/reperfusion — Ready for translationJournal of Molecular and Cellular Cardiology, 2011
- Heart Disease and Stroke Statistics—2011 UpdateCirculation, 2011
- cAMP/CREB-mediated Transcriptional Regulation of Ectonucleoside Triphosphate Diphosphohydrolase 1 (CD39) ExpressionJournal of Biological Chemistry, 2010
- Apyrase treatment of myocardial infarction according to a clinically applicable protocol fails to reduce myocardial injury in a porcine modelBMC Cardiovascular Disorders, 2010
- CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel diseaseProceedings of the National Academy of Sciences of the United States of America, 2009
- Central role of Sp1-regulated CD39 in hypoxia/ischemia protectionBlood, 2009
- CD39/Ectonucleoside Triphosphate Diphosphohydrolase 1 Provides Myocardial Protection During Cardiac Ischemia/Reperfusion InjuryCirculation, 2007
- Cardioprotection by Ecto-5′-Nucleotidase (CD73) and A 2B Adenosine ReceptorsCirculation, 2007
- Use of Adult Mesenchymal Stem Cells Isolated from Bone Marrow and Blood for Somatic Cell Nuclear Transfer in PigsCloning and Stem Cells, 2006